Engineered Biomaterials Control Differentiation and Proliferation of Human-Embryonic-Stem-Cell-Derived Cardiomyocytes via Timed Notch Activation  by Tung, Jason C. et al.
Stem Cell Reports
ReportEngineered Biomaterials Control Differentiation and Proliferation of Human-
Embryonic-Stem-Cell-Derived Cardiomyocytes via Timed Notch Activation
Jason C. Tung,1 Sharon L. Paige,2,4 Buddy D. Ratner,1 Charles E. Murry,1,2,3,4,5,* and Cecilia M. Giachelli1,5,*
1Department of Bioengineering, University of Washington, Seattle, WA 98195, USA
2Department of Pathology, University of Washington, Seattle, WA 98195, USA
3Department of Medicine/Cardiology, University of Washington, Seattle, WA 98195, USA
4Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA
5These authors contributed equally to this work
*Correspondence: murry@uw.edu (C.E.M.), ceci@u.washington.edu (C.M.G.)
http://dx.doi.org/10.1016/j.stemcr.2014.01.011
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYFor cell-based treatments of myocardial infarction, a better understanding of key developmental signaling pathways and more robust
techniques for producing cardiomyocytes are required.Manipulation of Notch signaling has promise as it plays an important role during
cardiovascular development, but previous studies presented conflicting results that Notch activation both positively and negatively reg-
ulates cardiogenesis.We developed surface- andmicroparticle-based Notch-signaling biomaterials that function in a time-specific activa-
tion-tunable manner, enabling precise investigation of Notch activation at specific developmental stages. Using our technologies, a
biphasic effect of Notch activation on cardiac differentiationwas found: early activation in undifferentiated human embryonic stem cells
(hESCs) promotes ectodermal differentiation, activation in specified cardiovascular progenitor cells increases cardiac differentiation.
Signaling also induces cardiomyocyte proliferation, and repeated doses of Notch-signaling microparticles further enhance cardiomyo-
cyte population size. These results highlight the diverse effects of Notch activation during cardiac development and provide approaches
for generating large quantities of cardiomyocytes.INTRODUCTION
Specific control of cellular fate by biological surface modi-
fication has garnered recent attention for the ability to
create biomimetic microenvironments (Lutolf and Hub-
bell, 2005). Normally, the body contains stem cell niches
composed of complex, spatially and temporally controlled
mixtures of soluble chemokines, insoluble extracellular
matrix molecules, and cells expressing transmembrane
receptor ligands that direct cell fate. Much focus has
been given to modifying surfaces to mimic these stem
cell niche microenvironments in order to control cellular
fate (Lutolf and Hubbell, 2005; Keselowsky et al., 2005;
Hoffman and Hubbell, 2004). In these studies, molecular
immobilization is proposed to have a critical role by
increasing protein stability, promoting persistent signal-
ing, and inducing receptor clustering (Irvine et al.,
2002). Despite the attention given to mimicking stem
cell niches via surface modifications, few studies have uti-
lized cell-cell surface-ligand-receptor interactions for con-
trolling cellular fate.
One particularly promising cell-surface pathway is the
Notch pathway, which has been shown to play an impor-
tant role in development and normal cell function, regu-
lating such events as cell growth, proliferation, survival,
migration, and differentiation (Artavanis-Tsakonas et al.,
1999). The Notch pathway is initiated upon binding of aStem Ccell-surface-bound Notch ligand with a Notch receptor
on a second cell, triggering two proteolytic cleavages
that release the Notch intracellular domain (NICD) from
the plasma membrane. Once released, the NICD translo-
cates to the nucleus where it binds to and converts the
CSL transcription factor from a transcriptional repressor
to an activator, allowing for Notch target-gene transcrip-
tion (Bray, 2006; Mumm and Kopan, 2000). Activation
of the pathway contributes to numerous cell-fate decisions
including maintenance of hematopoietic stem cells in an
undifferentiated state (Varnum-Finney et al., 2000b), in-
duction of endothelial-to-mesenchymal transformation
(Noseda et al., 2004), expansion of neural precursors
(Oishi et al., 2004), and inhibition of differentiation
toward an osteoblastic phenotype (Sciaudone et al.,
2003). During cardiac morphogenesis, the Notch signaling
pathway is crucial as Notch perturbation has been
implicated in the pathogenesis of various human car-
diovascular diseases (Nemir and Pedrazzini, 2008; Joutel
and Tournier-Lasserve, 1998). However, past studies have
presented conflicting conclusions, stating that Notch acti-
vation can both promote and inhibit cardiac differentia-
tion (Schroeder et al., 2003; Nemir et al., 2006; Noggle
et al., 2006; Jang et al., 2008; Lowell et al., 2006; Chen
et al., 2008; Fox et al., 2008; Yu et al., 2008). Thus, we
hypothesized that Notch signaling plays multiple roles
in cardiac development from human embryonic stemell Reports j Vol. 2 j 271–281 j March 11, 2014 j ª2014 The Authors 271
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context-dependent.
Because the Notch pathway is a cell-cell signaling
pathway, unique approaches must be taken to successfully
activate signaling. Common approaches include in vitro
coculture with Notch-ligand-presenting cells (Neves
et al., 2006) and transfection with constitutively active
forms of the NICD. Unfortunately, these approaches
possess several disadvantages. Coculture systems result
in unrelated cell-to-cell interactions, and heterogeneity
between cell lines and cell-culture conditions may induce
varying levels of ligand expression (Sokolova and Epple,
2008). Overexpression of the NICD results in the pathway
being permanently activated, when often only transient
activation is desired. Gene transfection also results in het-
erogeneous conditions, whereas transfection efficiency
and cytotoxicity may compromise cell viability and
normal gene expression. In addition, because of the
ability of Notch ligands to bind with multiple Notch
receptors, genetic modifications that serve to over-
activate single Notch receptors may fail to properly
address the complexity of Notch activation. The use of
genetically modified Notch receptors can also result in
the expression of Notch receptors at nonphysiologic
levels. Notch-activating surface modifications avoid these
issues through the engineering of homogenous surfaces
that allow for precise activation of the Notch signaling
pathway. As previously published by our group, compared
to soluble treatment and nonspecific immobilization of a
Notch ligand, oriented ligand immobilization results in a
more potent induction of Notch-mediated epithelial dif-
ferentiation in vitro and in a neonatal foreskin-rafted
organ culture model (Beckstead et al., 2006, 2009).
Compared to use of a soluble ligand that can act as a
Notch agonist or antagonist depending on the context
(Artavanis-Tsakonas et al., 1999; Hicks et al., 2002; Var-
num-Finney et al., 2000a; Small et al., 2001), these
Notch-signaling surfaces provide an approach for pre-
cisely and reliably controlling Notch activation for use
in guiding cellular fate.
In the present study, we have engineered oriented
Notch-signaling biomaterials capable of precisely con-
trolling stem cell fate. In order to determine the
context-dependent effect of Notch activation on car-
diac development, Notch activation was precisely tar-
geted at several developmental stages. The effect of
oriented Jagged-1 surfaces on cardiomyocyte differen-
tiation at the pluripotent embryonic stem cell and car-
diovascular progenitor cell developmental stage were
assessed, and changes in terminally differentiated
human embryonic stem cell (hESC)-derived cardiomyo-
cyte proliferation following Notch activation were also
determined.272 Stem Cell Reports j Vol. 2 j 271–281 j March 11, 2014 j ª2014 The AuthRESULTS
Oriented Jagged-1 Immobilization on Surfaces and
Microparticles Activates Notch Signaling in a
Controllable Manner
An indirect immobilization scheme was used to control
Notch ligand surface orientation and increase Notch-
signaling activity. 125I radioactivity experiments demon-
strate that Jagged-1 can be indirectly immobilized on a
tissue culture polystyrene (TCPS) surface (Figure 1A). By
increasing precoat concentration, we observed dose-
dependent increases in Jagged-1 surface concentration,
eventually reaching a maximum surface concentration of
120 ng/cm2, an amount that corresponds to levels ex-
pected for a theoretical Jagged-1 proteinmonolayer. Activa-
tion of Notch signaling through the CSL-dependent
pathway in human embryonic kidney, neonatal (HEKn)
cells plated on our oriented Notch ligand surfaces was
analyzed via aCBF-1 luciferase assay. Oriented Jagged-1 sur-
faces incubated in at least 7 nM Jagged-1 precoat solutions
resulted in a 3-fold or greater increase in Notch/CBF-1
signaling at 24 hr postplating compared to TCPS control
(Figure 1B). By further increasing the Jagged-1 incubation
solution concentration, a greater than 4-fold increase could
be observed.
In order to repeatedly activate Notch signaling without
the need to replate cells, an oriented Jagged-1-modified
fibrin microparticle signaling platform was developed.
Using an aqueous in oil stirred emulsion approach, fibrin
microparticles with an approximate diameter of 40 mm
were synthesized (Figure 1C). As was done with our
surfaces, Jagged-1 was bound to fibrin microparticles via
an indirect immobilization approach. Utilizing free termi-
nal carboxyl groups on the fibrin microparticles, 1-ethyl-
3-[3-dimethylaminopropyl]carbodiimide hydrochloride/
N-hydroxysulfosuccinimide (EDC/NHS) chemistry was
used to create amine-reactive sulfo-NHS esters, allowing
covalent attachment of antipolyhistidine molecules via
their free primary amines and subsequent formation of
amide bonds. Subsequent incubation in Jagged-1 solutions
resulted in the affinity immobilization of Jagged-1 on anti-
polyhistidine-modified fibrin microparticles. 125I radio-
labeled Jagged-1 served to confirm immobilization to fibrin
microparticles (Figure 1D). Additionally, the quantity of
Jagged-1 immobilized to fibrin microparticles could be
fine-tuned in a dose-dependent manner by varying
Jagged-1 precoat solution concentration. The ability to
activate Notch signaling through the CSL-dependent
pathway was again determined via a HEKnCBF-1 luciferase
assay. Cells treated with oriented Jagged-1-modified fibrin
microparticles showed a dose-dependent activation of
Notch/CBF-1 signaling (Figure 1E), whereas no Notch acti-
vation was observed in the unmodified fibrinmicroparticleors
Figure 1. Characterization of Oriented
Jagged-1 Biomaterials
(A) 125I radiolabeling shows dose-depen-
dent increases in surface concentration of
Jagged-1 indirectly immobilized on a TCPS
surface. A maximum surface concentration
corresponding to levels expected for a
theoretical Jagged-1 protein monolayer
was achieved.
(B) CBF-1 luciferase assays measuring
Notch/CSL signaling in HEKn cells plated on
oriented Jagged-1 surfaces show a dose-
dependent increase in signal activation.
(C) A stirred emulsion reaction mixture
generates 40 mm diameter fibrin micropar-
ticles.
(D) 125I radiolabeling showing the dose-
dependent indirect immobilization of
Jagged-1 on fibrin microparticles.
(E) CBF-1 luciferase assay results measuring
Notch/CSL signaling in HEKn cells treated
with oriented Jagged-1-modified fibrin
microparticles at various ratios, unmodified
fibrin microparticles, or oriented Jagged-1-
positive control surface. Cells treated with
oriented Jagged-1-modified fibrin micro-
particles showed a dose-dependent activa-
tion of Notch/CBF-1 signaling. Results are
representative of three independent ex-
periments and are mean ± SD, n = 3. Points
marked by a given symbol denote statistical
significance (p < 0.05 compared to points
that are unmarked or marked by a different
symbol).
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ented Jagged-1 surface- and microparticle-based signaling
platforms not only activate Notch signaling but do so in
a highly controllable and predictable manner.
Jagged-1-Mediated Notch Activation in
Undifferentiated hESCs Increases Ectodermal Gene
Expression
Because we believed the role of Notch activation in cardio-
genesis to be time-specific, we began by investigating the
role of Notch activation in the differentiation of pluripo-Stem Ctent embryonic stem cells (ESCs). To determine this,
undifferentiated hESCs maintained in mouse-embryonic-
fibroblast-conditioned media were replated in serum-
containing media on either control surfaces or oriented
Jagged-1 surfaces. As displayed in our control samples
without Notch activation, these conditions initiated spon-
taneous differentiation and departure of ESCs from the
pluripotent state. In hESCs plated on oriented Jagged-1
surfaces, expression of the Notch target gene, HES1, was
significantly increased compared to control surfaces,
demonstrating Notch-signaling activation (Figure 2A). Allell Reports j Vol. 2 j 271–281 j March 11, 2014 j ª2014 The Authors 273
Figure 2. The Role of Notch Signaling
Activation in the Differentiation of
Human Pluripotent Embryonic Stem Cells
Undifferentiated human embryonic stem
cells were plated on control or oriented
Jagged-1 surfaces, and gene expression was
analyzed via quantitative PCR (qPCR) up to
8 days after initial plating. Notch gene:
HES1; pluripotency gene: OCT4; mesodermal
gene: BRACHYURYT; endodermal gene:
FOXA2; ectodermal gene: SOX1.
(A) hESCs plated on oriented Jagged-1
surfaces display increased expression of the
Notch target gene, HES1, peaking 1 day
after plating, indicating successful activa-
tion of the Notch pathway via oriented
Jagged-1 surfaces.
(B–E) Activation of Notch signaling does
not alter pluripotency, mesoderm, or
endoderm gene expression compared to
controls but does increase ectodermal gene
expression. Results are representative of
three independent experiments and are
mean ± SD, n = 3; symbols denote p < 0.05
compared to controls.
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OCT4 pluripotency gene and upregulatedmarkers of meso-
derm formation (BRACHYURYT) and endoderm formation
(FOXA2) in a comparable manner (Figures 2B–2D). In
contrast, a sustained increase (>2-fold) expression of the
ectodermal gene, SOX1, was observed on oriented Jagged-1
surfaces compared to control surfaces (Figure 2E). Thus,
Jagged-1-mediated Notch activation encourages ecto-
dermal gene expression in undifferentiated hESCs, demon-
strating a relationship between Jagged-1-mediated Notch
activation and ectoderm formation at this early develop-
mental time point.274 Stem Cell Reports j Vol. 2 j 271–281 j March 11, 2014 j ª2014 The AuthOriented Jagged-1 Surfaces Promote Cardiomyocyte
Differentiation of KDR+ Progenitor Cells
Next, we sought to determine the effect of Notch activation
at a later multipotent cardiac progenitor developmental
stage. KDR+ cardiovascular progenitor cells are a multipo-
tent cell population with the capacity to differentiate into
endothelial, smooth muscle, and cardiac cell types (Yang
et al., 2008). For our experiments, we generated popula-
tions enriched for KDR+/platelet-derived-growth-factor-
receptor-a-positive progenitor cells (>90%). This cell
population actively expresses mRNA transcripts of the
Notch ligand, JAGGED-1, and the Notch target gene,ors
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(Figure 3A), suggesting that Jagged-1-mediated Notch acti-
vation can occur in this cell population.
To determine whether Jagged-1-mediated Notch activa-
tion influences their differentiation, KDR+ progenitors
(>90% purity) were plated on oriented Jagged-1 surfaces.
In culture, beating loci were observed on oriented Jagged-1
surfaces 8 days after plating, whereas cells on control sur-
faces did not exhibit any contractions until 12 days after
plating. At 12 days after plating, fluorescence-activated
cell sorting (FACS) analysis demonstrated that Jagged-1-
induced Notch activation in KDR+ progenitor cells resulted
in a >20-fold increase in the percent of cells expressing car-
diac troponin T (TNNT2) (from 3% to 70%), roughly a
50% decrease in the population of smooth muscle actin+
cells (from 14% to 7%), and no significant change in
CD31+ endothelial cells (Figures 3C–3F). This Notch-medi-
ated increase in cardiac differentiation resulted in an 8-fold
increase in cardiac differentiation efficiency (Figure 3G), as
every KDR+ progenitor cell plated on an oriented Jagged-1
surface generated roughly two TNNT2+ cardiomyocytes,
whereas control surfaces required more than four KDR+
progenitors to generate a single TNNT2+ cardiomyocyte.
Additionally, cardiomyocytes expressed the cardiac tran-
scription factor NKX2.5 and the cytoskeletal protein
a-actinin, with a-actinin staining displaying the striations
characteristic of sarcomeric formation (Figure 3B). Perhaps
the most striking difference in these differentiated cardio-
myocytes is observed in culture, as these differentiated car-
diomyocytes form sheets of spontaneously beating cells,
with synchronous waves of contraction propagating
throughout the entire culture (Movie S1 available online).
These results demonstrate that Jagged-1-mediated Notch
activation through oriented Jagged-1 surfaces provides a
nongenetic approach capable of inducing highly efficient
cardiac differentiation in human KDR+ progenitor cells.
Combined with the results from our undifferentiated
hESC studies, these findings demonstrate a biphasic effect
of Notch activation during cardiac differentiation and
highlight the temporally dependent nature of Notch
signaling.
Oriented Jagged-1 Surfaces Induce hESC-derived
Cardiomyocyte Proliferation
Upon determining context-specific effects of Notch activa-
tion on cardiac differentiation, we sought to determine the
role of Notch activation in guiding the development of
terminally differentiated cardiomyocytes. hESC-derived
MYH7+ cardiomyocytes exhibit significant increases in
mRNA levels of the Notch ligand, JAGGED-1, and the
Notch signaling target gene, HES1, compared to an undif-
ferentiated hESC population (Figure 4A). These results
demonstrate JAGGED-1 expression and HES1 transcriptionStem Cin hESC-derived MYH7+ cardiomyocytes, suggesting that,
like the KDR+ progenitor cells, Jagged-1-mediated Notch
activation can occur in definitive cardiomyocytes.
hESC-derived MYH7+ cardiomyocytes were plated on
several surfaces to determinewhether Notch-signaling acti-
vation could promote cardiac proliferation. We found that
55% of cardiomyocytes plated on oriented Jagged-1 sur-
faces exhibited positive staining for bromodeoxyuridine
(BrdU) incorporation, a significant increase compared to
42% of cardiomyocytes plated on control surfaces (Figures
4B and S1). This is the most robust mitogen we have found
to date for hESC-derived cardiomyocytes, significantly sur-
passing the 47% BrdU incorporation rates observed with
insulin growth factor 1 (IGF-1) (McDevitt et al., 2005).
Additionally, ɣ-secretase inhibitor treatment, which blocks
the proteolytic activation of the Notch intracellular
domain, inhibited this increase in proliferation, signifi-
cantly decreasing the proliferative cardiomyocyte popula-
tion to 38%, and verifying that the proliferative effects of
oriented Jagged-1 surfaces are indeed Notch mediated.
Interestingly, ɣ-secretase inhibitor treatment of cardiomyo-
cytes plated on gelatin control surfaces served to further
decrease the proliferative population to 33%, suggesting
that basal hESC-derived cardiomyocyte proliferation is
partially a result of endogenous levels of Notch signaling.
Lastly, unoriented Jagged-1 surfaces synthesized by non-
specific protein adsorption displayed proliferative levels
(43%) significantly lower than oriented Jagged-1 surfaces
and more analogous to control surfaces, demonstrating
that the Jagged-1 immobilization technique influences
the capacity of Notch-signaling surfaces to induce prolifer-
ation in hESC-derived cardiomyocytes. These results high-
light the ability of oriented Jagged-1 surfaces to induce
Notch-mediated proliferation of hESC-derived cardiomyo-
cytes, highlighting yet another distinct developmental
stage at which Notch signaling displays potent effects.
Oriented Jagged-1-Modified Fibrin Microparticles
Induce the Proliferation of hESC-Derived
Cardiomyocytes
While effective for inducing Notch signaling at a singular
time point, oriented Jagged-1 surfaces only result in an
initial spike in Notch activation. To achieve greater versa-
tility of Notch activation, we developed a microparticle-
based Notch-signaling platform, which through repeated
addition of modified microparticles allows for sustained
signaling activation or activation at multiple distinct time
points. hESC-derived MYH7+ cardiomyocytes were treated
with oriented Jagged-1-modified fibrin microparticles to
determine if this technology could successfully induce pro-
liferation in differentiated cardiomyocytes. We found that
44% of cardiomyocytes treated with oriented Jagged-1-
modified fibrin microparticles at a 1:1 cell:particle ratioell Reports j Vol. 2 j 271–281 j March 11, 2014 j ª2014 The Authors 275
Figure 3. The Role of Notch Signaling Activation in the Differentiation of KDR+ Cardiovascular Progenitor Cells
For analysis of differentiation, KDR+ cardiovascular progenitor cells were plated on control or oriented Jagged-1 surfaces in defined
medium. Following 12 days in culture, cells were analyzed for cardiac differentiation.
(legend continued on next page)
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Notch-Signaling Materials Generate Cardiomyocytesincorporated BrdU, a statistically significant increase from
the 32% incorporation rate observed in controls exposed
to particles containing only the antipolyhistidine modifi-
cation (Figure 4C). In addition, this increase in cardiomyo-
cyte proliferation matched that of cardiomyocytes plated
on oriented Jagged-1 surfaces, indicating that our micro-
particle-based signaling platform is an equally effective
activator of Notch signaling. Importantly, no statistically
significant difference was observed in cardiomyocytes
treated with antipolyhistidine-modified fibrin microparti-
cles compared to cells plated on a gelatin surface, demon-
strating that the increase in cardiomyocyte proliferation
is specifically due to the immobilization of Jagged-1 on
fibrin microparticles and not due to a nonspecific effect
of the particles. Cells treated with unoriented Jagged-1-
modified fibrin microparticles at a 1:1 cell:particle ratio
exhibited only 32% BrdU incorporation, indicating that
unoriented Jagged-1-modified fibrin microparticles are
unable to induce cardiomyocyte proliferation. A dose-
response curve showed that cardiomyocytes treated with
one particle per two cells had significantly increased prolif-
eration compared to controls (38% versus 32%), and still
higher proliferation rates were observed with a 1:1
particle:cell ratio (44%). These studies demonstrate that
oriented Jagged-1-modified fibrin microparticles are
capable of inducing proliferation in hESC-derived cardio-
myocytes in a dose-dependent manner.
As our Notch-signaling microparticles possess the ability
to repeatedly activate Notch signaling, we sought to
demonstrate the utility of this technology by attempting
to further heighten cardiomyocyte population growth via
the administration of multiple treatments. hESC-derived
cardiomyocytes were subjected to multiple doses of
modified microparticles, and cell population growth was
measured over a 5-day time span. Compared to oriented
Jagged-1 surfaces, which served to increase cell numbers
by about 4-fold after 5 days (3-fold increase in controls),
cardiomyocytes receiving two 1:1 cell:particle doses of ori-
ented Jagged-1-modified fibrin microparticles 2 days and(A) mRNA gene expression demonstrates transcription of the Notch l
(B) Immunofluorescent staining illustrates the presence of a-ACTININ
stained positively for a-ACTININ and display striations characteristic
transcription factor NKX2.5, with staining localized primarily in the n
(C–E) FACS analysis displays that plating KDR+ cells on oriented Ja
increase in cardiomyocyte differentiation and 10% decrease in smooth
shown.
(F) Summary of FACS analysis demonstrates that, after plating on ori
endothelial differentiation (CD31), but significant decreases in smoot
in cardiomyocyte (CARDIAC TROPONIN T, TNNT2) differentiation are o
(G) The efficiency of cardiomyocyte differentiation increases on orie
vascular progenitor cells required to generate TNNT2+ cardiomyocyte
are mean ± SD, n = 3; symbols denote p < 0.05 compared to controls
Stem C4 days after plating displayed >6-fold increase in cell
number (Figure 4D). These results demonstrate that
repeated dosing with Notch-signaling microparticles has
potential for the large-scale generation of hESC-derived
cardiomyocytes.DISCUSSION
In the present study, we describe the development of
several oriented Notch-signaling biomaterials and their
use in generating hESC-derived cardiomyocytes. Our re-
sults indicate that Notch activation has a biphasic effect
over the course of human cardiac differentiation, favoring
ectodermal differentiation at an undifferentiated pluripo-
tent stem cell stage and increasing cardiac differentiation
at the KDR+ cardiovascular progenitor stage. Additionally,
Notch activation induces proliferation in the differentiated
cardiomyocyte cell population. Importantly, by taking a
physiologically relevant approach and triggering Notch
activation through the presentation of a Notch ligand
and not through the use of constitutively active or drug-
inducible Notch receptors, these findings demonstrate
the natural potential of Notch activation to influence mul-
tiple stages of human cardiac development. These results
highlight the temporally dependent potent effects of
Notch activation and suggest that Notch-signaling tech-
nologies may be of value for generating differentiated car-
diomyocytes for clinical applications.
Recent studies have begun to investigate the role of
Notch signaling in guiding cardiogenic fate decisions.
Several studies have demonstrated that Notch inhibition
through either expression of defective RBP-Jk (Schroeder
et al., 2003), Notch1-deficient cells (Nemir et al., 2006),
or treatment with the gamma secretase inhibitors (Noggle
et al., 2006; Jang et al., 2008) can both promote or inhibit
cardiomyocyte differentiation, whereas Notch activation
in cells as observed through reporter gene activation
(Nemir et al., 2006) or activation through DLL1-expressingigand, JAGGED-1, and the Notch target gene, HES1, in KDR+ cells.
and NKX2.5 in KDR+ cells plated on oriented Jagged-1surfaces. Cells
of sarcomeric formation. Cells also costain positively for the cardiac
ucleus. (603 magnification).
gged-1 surfaces (compared to control surfaces) results in a >60%
muscle differentiation after 12 days in culture. Representative plots
ented Jagged-1 surfaces, KDR+ cells show no significant change in
h muscle cell differentiation (SMOOTH MUSCLE ACTIN) and increases
bserved.
nted Jagged-1 surfaces as defined by the number of KDR+ cardio-
s. Results are representative of three independent experiments and
.
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Figure 4. Effects of Oriented Jagged-1
Biomaterial-Mediated Notch-Signaling
Activation on the Induction of Cardio-
myocyte Proliferation
After attachment, differentiated MYH7+
cardiomyocytes were stimulated as de-
scribed for 48 hr in serum-free media and
labeled with BrdU during the last 24 hr
of treatment, at which point induction of
proliferation was determined via immuno-
staining.
(A) qPCR analysis of mRNA gene expression
demonstrates transcription of the Notch
ligand, JAGGED-1, and the Notch-signaling
target gene, HES1, in hESC-derived MYH7+
cardiomyocytes.
(B) BrdU proliferation assays demonstrate
induction of hESC-derived cardiomyocyte
proliferation. MYH7+ cardiomyocytes plated
on oriented Jagged-1 surfaces display sta-
tistically significant greater levels of pro-
liferation compared to controls. ɣ-secretase
inhibitor treatment reverses the prolifera-
tive effects of oriented Jagged-1 surfaces,
verifying that oriented Jagged-1 surface
bioactivity is Notch specific. The mode
of Jagged-1 immobilization also plays a
considerable role in the effectiveness of
Jagged-1 surfaces to induce proliferation,
as randomly oriented Jagged-1 surfaces
are unable to induce cardiomyocyte prolif-
eration.
(C) Treatment with oriented Jagged-1-
modified fibrin microparticles results in a
significant increase in cardiomyocyte pro-
liferation as measured by BrdU incorpora-
tion. Method of Jagged-1 immobilization
influences the microparticle bioactivity as
oriented Jagged-1-modified fibrin micro-
particles successfully induce cardiomyocyte
proliferation, whereas cardiomyocytes treated with unoriented Jagged-1-modified fibrin microparticles display proliferation levels similar
to negative controls. The degree of cardiomyocyte proliferation is further controlled in a dose-dependent manner by oriented Jagged-1-
modified fibrin microparticles through adjustment of the particle:cell ratio.
(D) Oriented Jagged-1-modified fibrin microparticles can repeatedly induce cardiomyocyte proliferation to further heighten population
growth. Oriented Jagged-1 surfaces accelerate cardiomyocyte population growth compared to controls, whereas repeated treatment with
oriented Jagged-1-modified fibrin microparticles further increases the rate of cardiomyocyte population growth. Results are representative
of three independent experiments and are mean ± SD, n = 7 (A–C) or 3 (D). Conditions marked by a given symbol denote statistical
significance (p < 0.05 compared to experimental groups that are unmarked or marked by a different symbol).
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diac differentiation in favor of neuroectoderm formation.
At a more specified developmental stage, timed activation
of Notch signaling in cardiac mesoderm promotes cardiac
development, whereas Notch activation in mouse-derived
hemangioblasts respecifies them to a cardiac cell fate
(Chen et al., 2008). In addition, the Notch signaling
pathway has been shown to be active in proliferating278 Stem Cell Reports j Vol. 2 j 271–281 j March 11, 2014 j ª2014 The Authneonatal rat cardiomyocytes, with exogenous Notch acti-
vation serving to stimulate cardiomyocyte proliferation
and cell-cycle re-entry (Collesi et al., 2008; Campa et al.,
2008). Our results help to resolve some of the discrepancies
between these studies, showing that not only does Notch
signaling play a significant role in the differentiation and
proliferation of human cardiomyocytes, but the timing of
Notch activation is also critical, as pathway activationors
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Notch-Signaling Materials Generate Cardiomyocytescan have positive or negative effects on the generation of
human-derived cardiomyocytes depending on the devel-
opmental stage at which it is triggered.
In this study, we have shown that oriented Jagged-1 bio-
materials, immobilized on either a solid surface or micro-
particles, are able to precisely activate the Notch signaling
pathway for use in controlling cellular fate. In guiding car-
diomyocyte development, we have demonstrated multiple
temporally distinct effects, where Notch activation at the
pluripotent state acts in an anticardiogenic manner by
favoring ectodermal differentiation and is procardiogenic
at later stages, serving to increase cardiac differentiation
in KDR+ progenitors and induce proliferation in differenti-
ated cardiomyocytes. Whereas the exact mechanism by
which the Notch signaling pathway exerts these effects
on differentiation in our system is unclear, reports have
suggested significant interaction between Notch and other
signaling pathways, including the transforming growth
factor b (TGF-b)/bone morphogenetic protein (BMP) (Guo
and Wang, 2009) and Wnt pathways (Hayward et al.,
2008). Interestingly, our results appear to coincide with
previous work that suggested that the Notch and TGF-b/
BMP pathways work synergistically, whereas Notch in-
hibits the Wnt pathway during the process of cardiomyo-
cyte-directed differentiation (Chen et al., 2008). These
results demonstrate the importance of timing Notch
activation, as pathway activation can have positive or
negative effects on cardiomyocyte differentiation depend-
ing on the developmental stage at which signaling is
activated.
Our studies utilized the Notch ligand Jagged-1 for
inducing Notch activation. Previous studies have high-
lighted the contrasting effects stemming from activating
the Notch signaling pathway via the Delta versus the
Jagged ligand family in various organs and tissues,
including the developing nervous and immune systems
(Amsen et al., 2004; Brooker et al., 2006). In addition, a
family of glycosyltransferases called Fringe proteins are
known to modify O-fucose on Notch receptors through
the addition of N-acetylglucosamine, a modification that
serves to restrict activation of Notch receptors to only
Delta ligands, inhibiting Jagged-mediated Notch activa-
tion (Haines and Irvine, 2003). In future studies, investi-
gating the effects of Fringe proteins or Delta-mediated
Notch activation in our systems would serve to provide
even further clarity on the precise role of Notch signaling
in guiding cellular fate decisions at these developmental
stages.
Our data suggest that surfaces remain active primarily
over the course of 24 hr. Decreased activity after this time
period may result from either inadequate amounts of
ligand remaining on the surfaces or self-regulation of the
Notch pathway, as most Notch-mediated processes requireStem Conly a transient pulse of activity that in some cases lasts
only a fraction of the cell cycle (Ambros, 1999). We were
able to surpass the effects of oriented Jagged-1 surfaces
through treatment with multiple doses of Notch-signaling
microparticles, demonstrating the promise of using this
technology to repeatedly activate or maintain Notch
signaling activation. Though useful, this technology may
possess several limitations. Previous studies have demon-
strated that, during neonatal rat cardiomyocyte matura-
tion, expression levels of Notch-signaling components
are actually downregulated over time (Collesi et al.,
2008), serving to limit the proliferation of the maturing
cardiomyocyte population. As both of our Notch-signaling
platforms require expression of endogenous Notch recep-
tors in our cells of interest in order to achieve successful
Notch activation, the aging of hESC-derived cardiomyo-
cytes in culture may limit their responsiveness to our
Notch-signaling technologies. In addition, as neonatal rat
cardiomyocytes mature and decrease Notch pathway activ-
ity, forced activation of the pathway results in pronounced
activation of DNA damage checkpoint, eventually leading
to mitotic arrest and cell apoptosis (Campa et al., 2008).
These findings again highlight the important role our engi-
neered signaling platforms can play in activating Notch
signaling in a physiologically relevant manner.
In conclusion, we have expanded on previous work
by demonstrating the potential application of Notch-
signaling surface modifications for use in precisely control-
ling cell-fate decisions at several developmental stages of
human cardiomyocyte development. Our findings suggest
several approaches that allow for more efficient hESC-
derived cardiomyocyte generation. Furthermore, because
the Notch signaling pathway plays a key context-depen-
dent role in numerous developmental processes, these
Notch-signaling biomaterials have the potential for
widespread application in directing cell-fate decisions in a
variety of cell systems.EXPERIMENTAL PROCEDURES
Preparation of Oriented JAG1 Biomaterials
Oriented JAG1 surfaces were fabricated using an indirect immobi-
lization scheme, and for antipolyhistidine control surfaces and
unoriented JAG1 surfaces, proteins were attached using a direct
immobilization scheme (Beckstead et al., 2006, 2009). Fibrin
microparticles were fabricated using a stirred-emulsion approach
and JAG1 indirectly immobilized using antipolyhistidine and
EDC/NHS chemistry.Human Embryonic Stem Cell Differentiation Assay
Undifferentiated hESCswere grown as described byXu et al. (2001)
and seeded onto oriented JAG1 surfaces, antipolyhistidine, or
Matrigel with differentiation analyzed via quantitative RT-PCR.ell Reports j Vol. 2 j 271–281 j March 11, 2014 j ª2014 The Authors 279
Stem Cell Reports
Notch-Signaling Materials Generate CardiomyocytesCardiovascular Progenitor Cell Differentiation Assay
KDR+ cardiovascular progenitor cells were generated via an
embryoid-body-based differentiation system (Yang et al., 2008)
and plated on either Matrigel, antipolyhistidine, or oriented
JAG1 surfaces. Differentiation was characterized via FACS and
immunofluorescent staining.
Human-Embryonic-Stem-Cell-Derived
Cardiomyocyte Proliferation Assay
hESC-derived MYH7+ cardiomyocytes were generated from KDR+
progenitors as described previously using oriented JAG1 surfaces.
Dissociated cardiomyocytes were replated in chamber slides
and treated as described. Proliferation was characterized via
AlamarBlue and immunostaining.
Statistical Analysis
Data were analyzed for significance using a one-way ANOVA and a
Tukey’s post hoc test for pairwise comparison. The software used
was SPSS for Windows and significance set at 95% confidence.
Detailed methods can be found in the Supplemental
Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, one figure, one table, and onemovie and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.
01.011.
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